Differential induction of FosB isoforms throughout the brain by fluoxetine and chronic stress
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Major depressive disorder is thought to arise in part from dysfunction of the brain's “reward circuitry,” consisting of the mesolimbic dopamine system and the glutamatergic and neuromodulatory inputs onto this system. Both chronic stress and antidepressant treatment regulate gene transcription in many of the brain regions that make up these circuits, but the exact nature of the transcription factors and target genes involved in these processes remain unclear. Here, we demonstrate induction of the FosB family of transcription factors in ∼25 distinct regions of adult mouse brain, including many parts of the reward circuitry, by chronic exposure to the antidepressant fluoxetine. We further uncover specific patterns of FosB gene product expression (i.e., differential expression of full-length FosB, ΔFosB, and Δ2ΔFosB) in brain regions associated with depression – the nucleus accumbens (NAc), prefrontal cortex (PFC), and hippocampus – in response to chronic fluoxetine treatment, and contrast these patterns with differential induction of FosB isoforms in the chronic social defeat stress model of depression with and without fluoxetine treatment. We find that chronic fluoxetine, in contrast to stress, causes induction of the unstable full-length FosB isoform in the NAc, PFC, and hippocampus even 24 hours following the final injection, indicating that these brain regions may undergo chronic activation when fluoxetine is on board, even in the absence of stress. We also find that only the stable ΔFosB isoform correlates with behavioral responses to stress. These data suggest that NAc, PFC, and hippocampus may present useful targets for directed intervention in mood disorders (ie, brain stimulation or gene therapy), and that determining the gene targets of FosB-mediated transcription in these brain regions in response to fluoxetine may yield novel inroads for pharmaceutical intervention in depressive disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Krishnan, V., Han, M.-H., Graham, D. L., Berton, O., Renthal, W., Russo, S. J., LaPlant, Q., Graham, A., Lutter, M., Lagace, D. C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.09.018 · Cited by 2,307
Self-citationEssential role of BDNF in the mesolimbic dopamine pathway in social defeat stress
Berton, O., McClung, C. A., DiLeone, R. J., Krishnan, V., Renthal, W., Russo, S. J., Graham, D., Tsankova, N. M., Bolanos, C. A., Rios, M., et al. (2006) · Science · doi:10.1126/science.1120972 · Cited by 2,129 · cited 5×
“…are administered chronically, and indeed require weeks of administration to produce behavioral effects in humans (Culpepper, 2010) and in CSDSmice (Berton et al., 2006), they likely alter the function of brain regions not directly affected by blockade of serotonin reuptake, but that are…”
InfluentialSelf-citationSynaptic Dysfunction in Depression: Potential Therapeutic Targets
Duman, R. S., & Aghajanian, G. K. (2012) · Science · doi:10.1126/science.1222939 · Cited by 1,651 · cited 2×
“…et al., 2010, 2014), and we chose hippocampus because is both modulates the function of the mesolimbic and mesocortical dopamine system and has been directly implicated in many studies of depression, both in humans and in pre-clinical models (Duman and Aghajanian, 2012; Eisch and Petrik, 2012).”
A standardized protocol for repeated social defeat stress in mice
Golden, S. A., Covington, H. E., Berton, O., & Russo, S. J. (2011) · Nature Protocols · doi:10.1038/nprot.2011.361 · Cited by 1,581 · cited 4×
“Chronic (10 days) social defeat stress and social interaction tests were performed essentially as described (Krishnan et al., 2007; Golden et al., 2011).”
InfluentialTranscriptional and epigenetic mechanisms of addiction
Robison, A. J., & Nestler, E. J. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3111 · Cited by 993
Self-citationThe Genetics of Major Depression
Flint, J., & Kendler, K. S. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.027 · Cited by 724 · cited 2×
“In recent decades, it has become increasingly clear that the variability in depressive disorders and in the response to existing treatments stems, at least in part, from individual differences in both genetics (Flint and Kendler, 2014) and gene expression (Vialou et al., 2013).”
Depression and Hippocampal Neurogenesis: A Road to Remission?
Eisch, A. J., & Petrik, D. (2012) · Science · doi:10.1126/science.1222941 · Cited by 516 · cited 2×
“…et al., 2010, 2014), and we chose hippocampus because is both modulates the function of the mesolimbic and mesocortical dopamine system and has been directly implicated in many studies of depression, both in humans and in pre-clinical models (Duman and Aghajanian, 2012; Eisch and Petrik, 2012).”
ΔFosB in brain reward circuits mediates resilience to stress and antidepressant responses
Vialou, V., Robison, A. J., LaPlant, Q. C., Covington, H. E., Dietz, D. M., Ohnishi, Y. N., Mouzon, E., Rush, A. J., Watts, E. L., Wallace, D. L., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2551 · Cited by 479
Self-citationVialou, V., Bagot, R. C., Cahill, M. E., Ferguson, D., Robison, A. J., Dietz, D. M., Fallon, B., Mazei-Robison, M., Ku, S. M., Harrigan, E., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1787-13.2014 · Cited by 283 · cited 10×
“Previous studies indicate that the transcription factorDFosB is induced by both chronic stress and chronic antidepressant treatment, and that it plays an essential role in mouse models of depression and antidepressant action (Perrotti et al., 2004; Vialou et al., 2010; Ohnishi et al., 2011; Lobo et al., 2013; Robison…”
InfluentialSelf-citationEpigenetic Mechanisms of Depression and Antidepressant Action
Vialou, V., Feng, J., Robison, A. J., & Nestler, E. J. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134540 · Cited by 277 · cited 3×
“In recent decades, it has become increasingly clear that the variability in depressive disorders and in the response to existing treatments stems, at least in part, from individual differences in both genetics (Flint and Kendler, 2014) and gene expression (Vialou et al., 2013).”
Self-citation
Cited by
Castro, D. C., & Bruchas, M. R. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.003 · Cited by 290
∆FosB: A transcriptional regulator of stress and antidepressant responses
Nestler, E. J. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.10.034 · Cited by 220
“More recently, we demonstrated that ΔFosB is induced in the pre-limbic mPFC selectively in susceptible mice, and that overexpression of ΔFosB in this region, but not in the nearby infra-limbic area, enhances stress susceptibility (Vialou et al., 2014a).”
BackgroundInfluentialSelf-citationTurcotte-Cardin, V., Vahid-Ansari, F., Luckhart, C., Daigle, M., Geddes, S. D., Tanaka, K. F., Hen, R., James, J., Merali, Z., Béïque, J.-C., et al. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.0352-18.2018 · Cited by 36
“FosB cells were done as described previously (Vialou et al., 2015; Vahid-Ansari and Albert, 2018) using 1 field/brain region, 1 section/area except raphe (4 sections), with the number and sex of animals shown as data points in figures.”
MethodKoketsu, S., Matsubara, K., Ueki, Y., Shinohara, Y., Inoue, K., Murakami, S., & Ueki, T. (2024) · Heliyon · doi:10.1016/j.heliyon.2023.e23738 · Cited by 5
Metadata
- Authors
- Vialou, V., Thibault, M., Kaska, S., Cooper, S., Gajewski, P., Eagle, A., Mazei-Robison, M., Nestler, E. J., & Robison, A. J.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 99
- Pages
- 28-37
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W1544881355
- Cited by
- 72
- References
- 13
- FWCI
- 4.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Differential induction of FosB isoforms throughout the brain by fluoxetine and chronic stress. https://app.cochat.ai/papers/10.1016/j.neuropharm.2015.07.005
- The paper
- Vialou, V., Thibault, M., Kaska, S., Cooper, S., Gajewski, P., Eagle, A., Mazei-Robison, M., Nestler, E. J., & Robison, A. J. (2015). Differential induction of FosB isoforms throughout the brain by fluoxetine and chronic stress. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2015.07.005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.